According to the information provided, the global pharmaceutical cold chain packaging market experienced significant growth between 2016 and 2022. The market size increased from US$6,249.2 million in 2016 to US$13,413 million in 2022, with an average compound annual growth rate (CAGR) of 13.3% during this period, even in the face of the pandemic lockdown and disruptions.
In 2023, the estimated total demand for pharmaceutical cold chain packaging is expected to be around US$15,176.2 million. Furthermore, the market analysis report suggests that the market will witness a higher CAGR of 14.8% through 2033. As a result, the overall valuation of the market is projected to reach US$60,100.9 million by the end of the forecast period.
The growing need for pharmaceutical cold chain packaging facilities is driven by the introduction of more complex biologically based medications. The increased shipment of vaccines, hormone therapies, and delicate proteins that require regulated temperature during transportation has also contributed to the market’s growth and attractiveness.
For More Insights on this Market, Get A Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13956
However, the adoption of pharmaceutical cold chain packaging services may face some constraints such as high costs and government regulations. These factors could impact the market’s growth to some extent.
Overall, the pharmaceutical cold chain packaging market has witnessed substantial growth and is expected to continue expanding in the future due to the increasing demand for temperature-controlled packaging for biologically based medications and other sensitive pharmaceutical products.
Key Takeaways
- The United States pharmaceutical cold chain packaging market generated a revenue of around US$ 2,494.5 million in the year 2022. This revenue share was around 18.6% of the global revenue making the United States the top region for the market.
- In Europe, Germany is the leading provider of pharmaceutical cold chain packaging services and contributes 3.8% to the global market share.
- In the Asia Pacific region, China tops in sales of pharmaceutical cold chain packaging services and other requirements for both domestic and adjacent markets. The net valuation of this regional market in 2022 was US$ 1,503.7 million and it is also progressing at a 17.7% growth rate.
Customize your report by selecting specific countries or regions and save 30% @ https://www.futuremarketinsights.com/customization-available/rep-gb-13956
Competitive Landscape for the Pharmaceutical Cold Chain Packaging Market Players
Sonoco ThermoSafe, Cold Chain Technologies, Sealed Air Corporation, Nordic Cold Chain Solutions, Cryopak, CSafe Global LLC, TemperPack Technologies, Inc., Insulated Product Corp., Global Cooling, Inc., Envirotainer AB, va-Q-tec AG, EMBALL’ISO, Softbox Systems, Sofrigam SAS, DGP Intelsius LLC, Tempack Packaging Solutions SL, TOWER Cold Chain Solutions, Pelican BioThermal LLC, Blue Star Limited, BIOBASE Group, Andores New Energy Co., Ltd., Haier Biomedical Co. Ltd., Tamai Kasei Co., Ltd., Dhruvraj Syndicate, Valor Industries, KODIAKOOLER, WoolCool Ltd., and Allwin Roto Plast among others are some prominent players in the global pharmaceutical cold chain packaging market.
Recent Developments
- Pelican BioThermal LLC bought NanoCool Company in February 2020 to expand its line of BioThermal products. After this, the Pelican firm was able to increase its connectivity to last-mile businesses, and laboratories by adding the latter’s customers, and regional market sectors.
- Sonoco ThermoSafe Company debuted their brand-new Pegasus ULD bulk temperature-controlled containers in September 2020. This is a proactive large temperature-controlled container for biopharmaceutical usage in the world and was certified as a unit load device by the FAA. It enables it to move swiftly and inexpensively through current international cargo transportation and customs procedures.
- In June 2020, Softbox introduced Tempcell ECO, which is an innovative curbside recyclable and thermostatic package shipper for the pharmaceutical cold chain market. It makes use of the company’s Thermaflute plastic-free insulating technology and is entirely comprised of corrugated cardboard material.
Enquire before purchasing this report @ https://www.futuremarketinsights.com/checkout/13956
Pharmaceutical Cold Chain Packaging Market by Category
By Packaging Format:
- Passive Packaging
- Single-use or One-way Use Packaging
- Multiple Use or Reusable Packaging
- Active Packaging
- Reefer Trucks and Containers
- Active Pallet Containers
By Product:
- Small Boxes
- Pallets
- Single Pallets
- Double Pallets
- Large Sized Pallet Containers
By Material:
- Polymer
- Polyethylene
- Polypropylene
- PET
- EPS
- Polyurethane
- Others
- Metal
- Paper
By Application:
- Biologics and Biological Samples
- Vaccines and Diagnostics
- Others
By End Use:
- Diagnostic Centers
- Clinical Research Organization
- Blood Banks
- Vaccines Packaging Industry
- Pharmaceuticals
- Other Healthcare Units
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa
About Us:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com